Aberrant Splicing Burden Predicts Immune Infiltration and Prognosis in Head and Neck Squamous Cell Carcinomas
Head & Neck · 2026
DOI: 10.1002/hed.70007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2026. Verfasst von Sandhya Kalavacherla und 5 weiteren Autor:innen. Beteiligte Einrichtung: Moores Cancer Center, UC San Diego Health, La Jolla, California, USA. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Alternative Splicing, Head and Neck Neoplasms, Carcinoma, Squamous Cell. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, V Foundation V Scholar Grant, NCI NIH HHS.
Abstract (Originalsprache)
Background
The role of alternative splicing events (ASEs) in immune evasion and prognosis in head and neck squamous cell carcinoma (HNSC) is not well characterized.
Methods
Using The Cancer Genome Atlas data, we identified ASEs (using our novel algorithm OutSplice) and characterized associations between splice burden, immune infiltration (quantified by xCell) and prognosis with multivariable logistic regression and survival models.
Results
HSNC tumors with low splice burden and high immune infiltration had significantly better prognosis than tumors with high splice burden and low immune infiltration when controlling for age, pathologic stage, HPV status, and tumor mutational burden (hazard ratio = 0.61). High splice burden predicted decreased immune infiltration in HNSC, which was validated in five other cancer types and supported by murine models of oral squamous cell carcinoma.
Conclusions
High splicing burden, as defined by OutSplice, is a novel biomarker to predict poor both immune infiltration and prognosis in HNSC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Moores Cancer Center, UC San Diego Health, La Jolla, California, USA.
- Department of Otolaryngology-Head and Neck Surgery, University of California, La Jolla, California, USA.
- Department of Otolaryngology-Head and Neck Surgery, Indiana University, Indianapolis, Indiana, USA.
- Division of Medical Genetics, Department of Medicine, University of California San Diego, San Diego, California, USA.
ORCID-Profile: Mitchell Victor
Förderung
- NIH HHS
- V Foundation V Scholar Grant
- NCI NIH HHS
- NCATS NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Kalavacherla, S., Bendik, J., Victor, M., Carter, H., Califano, J. A., & Guo, T. (2026). Aberrant Splicing Burden Predicts Immune Infiltration and Prognosis in Head and Neck Squamous Cell Carcinomas. Head & Neck. https://doi.org/10.1002/hed.70007
Vancouver
Kalavacherla S, Bendik J, Victor M, Carter H, Califano JA, Guo T. Aberrant Splicing Burden Predicts Immune Infiltration and Prognosis in Head and Neck Squamous Cell Carcinomas. Head & Neck. 2026. doi:10.1002/hed.70007
BibTeX
@article{Kalavacherla2026,
author = {Kalavacherla, Sandhya and Bendik, Joseph and Victor, Mitchell and Carter, Hannah and Califano, Joseph A and Guo, Theresa},
title = {Aberrant Splicing Burden Predicts Immune Infiltration and Prognosis in Head and Neck Squamous Cell Carcinomas},
journal = {Head & Neck},
year = {2026},
doi = {10.1002/hed.70007}
}
EUVIMED